Stephen Holgate MD DSc FRCP

Southampton University Hospital, United Kingdom

Speaking Agenda — Friday March 11

Graeme Copland Memorial Lecture 5:15 — 6.15pm


Stephen Holgate is Medical Research Council Clinical Professor of Immunopharmacology at the University of Southampton, UK. His clinical and research interests are in the mechanisms and treatment of asthma and allied disorders. This has spanned epidemiology, immunology, pharmacology, experimental medicine and genetics. Notable contributions have been in defining inflammatory and remodelling processes in asthma as they relate to different clinical phenotypes, identification of ADAM33 as the first novel asthma susceptibility gene and the mechanisms of acute exacerbations and the use of novel biologicals in therapy. On a broader front I chair the Population and Systems Medicine Board of the MRC and am a member of the MRC’s Strategy Board and the UK Government’s Translational Medicine Board. I have a particular interest in promoting Respiratory and Allergy Research, in increasing the translation of scientific discovery into patient benefit and the impact of the environment on human health.